Results 1 to 10 of about 1,729 (199)

Real‐Life Safety of Japanese Cedar Pollen Sublingual Immunotherapy Tablets: A Post‐Marketing Survey [PDF]

Clinical and Translational Allergy, Volume 16, Issue 2, February 2026.
We assessed the incidence of adverse drug reactions and effectiveness through two seasons of daily Japanese cedar (JC) pollen SLIT‐tablets 5000 JAU in Japan. Real‐life safety and effectiveness of JC pollen SLIT‐tablets appeared in patients with JC‐pollinosis.
Minoru Gotoh, Yuriko Maekawa, Tsuyoshi Ando, Noboru Kato, Eiji Horikawa, Noriaki Nishino   +5 more
wiley   +2 more sources

Are Respiratory Viruses Involved in Preseasonal Symptoms or Severity in Japanese Cedar Pollinosis? [PDF]

Allergy & Rhinology, 2016
Background Respiratory virus infections are involved in asthma exacerbations. However, there are no reports of the relationship between respiratory virus infections and Japanese cedar pollinosis.
Hirokuni Otsuka M.D., Hiroyuki Tsukagoshi Ph.D., Hirokazu Kimura M.D., Ikuo Takanashi Ph.D., Kimihiro Okubo M.D.   +4 more
doaj   +2 more sources

A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis [PDF]

, 2013
© Queen’s Printer and Controller of HMSO 2013Severe allergic rhinitis uncontrolled by conventional medication can substantially affect quality of life. Immunotherapy involves administering increasing doses of a specific allergen, with the aim of reducing
Barton, P, Dretzke, J, Fry-Smith, A, Huissoon, A, Kaambwa, B, Meadows, A, Meads, C, Novielli, N   +7 more
core   +1 more source

Study on inhibiting house dust mite allergens indoors and Japanese cedar pollen allergens outdoors by exposing to todomatsu oil produced from Abies Sachalinensis residues [PDF]

, 2023
埼玉大学博士（学術）主指導教員 : 王 青躍textapplication/pdfdoctoral ...
LIN, YICHUN, リン, イチュン
core   +1 more source

New Allergens Approved by the WHO/IUIS Allergen Nomenclature Sub‐Committee in 2021–2024 and Their Significance for Future Diagnostics, Regulation, and Research. An EAACI Task Force Report

Allergy, Volume 81, Issue 3, Page 684-699, March 2026.
ABSTRACT The WHO/IUIS Allergen Nomenclature Sub‐Committee is an international body of experts that maintains the systematic nomenclature of allergenic proteins by assigning official names to newly identified allergens submitted by researchers. Here, we summarize the data on new allergens approved between 2021 and 2024.
Christian Radauer, Gabriele Gadermaier, Richard E. Goodman, Alain Jacquet, Uta Jappe, Andreas L. Lopata, Anna Pomés, Monika Raulf, Keity S. Santos, Josefina Zakzuk, Yuzhu Zhang, Joana Vitte, on behalf of the WHO/IUIS Allergen Nomenclature Sub‐Committee   +12 more
wiley   +1 more source

Allergies respiratoires, pollens et polluants [PDF]

, 2005
National audienceFor 30 years, an increased incidence of respiratory allergy and asthma has been observed, particularly in children and young people living in urban areas of developed countries.
Aberg, Beasley, Behrendt, Bousquet, Chitano, Davies, Diaz-Sanchez, Diaz-Sanchez, Diaz-Sanchez, Diaz-Sanchez, Diaz-Sanchez, Duchateau, Emberlin, Fujimaki, Fujimaki, G. Lacroix, Haahtela, Hartl, Helleday, Ishizaki, Kobayashi, Koenig, Kogevinas, Lacroix, Lacroix, Latvala, Lebowitz, Luczynska, Marks, Masuch, Masuch, Motta, Motta, Motta, Muranaka, Nabe, Nel, Ninan, Obtulowicz, Ohta, Omura, Pandya, Pauli, Peat, Peltre, Perdrizet, Pourazar, Riedel, Riedl, Ruffin, Rusznak, Sandström, Shaw, Steerenberg, Suphioglu, Takafuji, Thomsen, von Hertzen, von Mutius, Weiland, Wiedermann   +60 more
core   +2 more sources

Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: A prospective, randomized, open-label study

Allergology International, 2015
Background: Short-term oral immunotherapy (OIT) using the Cry j1-galactomannan conjugate for Japanese cedar pollinosis may be effective and relatively safe. However, a treatment regimen has not been established.
Daisuke Murakami, Motohiro Sawatsubashi, Sayaka Kikkawa, Masayoshi Ejima, Akira Saito, Akio Kato, Shizuo Komune   +6 more
doaj   +1 more source

Factors Affecting the Number of Pollen Grains per Male Strobilus in Japanese Cedar (Cryptomeria japonica)

Plants, 2021
Japanese cedar (Cryptomeria japonica) is the most important timber species in Japan; however, its pollen is the primary cause of pollinosis in Japan. The total number of pollen grains produced by a single tree is determined by the number of male strobili
Hiroyuki Kakui, Eriko Tsurisaki, Rei Shibata, Yoshinari Moriguchi   +3 more
doaj   +1 more source

LP‐003, a novel high‐affinity anti‐IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double‐blind, placebo‐controlled phase 2 clinical trial

Clinical and Translational Allergy, Volume 15, Issue 6, June 2025.
Abstract Background Anti‐IgE therapy can serve as an option for inadequately controlled seasonal allergic rhinitis (SAR) patients. LP‐003, a novel anti‐IgE antibody, is being tested as an add‐on treatment for SAR. This trial aimed to evaluate whether LP‐003 is effective and safe for SAR.
Kai Guan, Shuang Liu, Yan Feng, Lisha Li, Xiaoming Zhu, Nai‐Chau‐Sun Bill, Haili Ma, Jie Yang, Cuicui Han, Heng Liu, Qingyu Wei, Haiyun Shi, Xueyan Wang   +12 more
wiley   +1 more source

Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen

Biomolecules, 2022
Allergen immunotherapy is a promising treatment for allergic diseases that induce immune tolerance through the administration of specific allergens. In this study, we investigate the efficacy of sublingual immunotherapy (SLIT) in asthmatic patients with ...
Shoko Ueda, Jun Ito, Norihiro Harada, Sonoko Harada, Hitoshi Sasano, Yuuki Sandhu, Yuki Tanabe, Sumiko Abe, Satomi Shiota, Yuzo Kodama, Tetsutaro Nagaoka, Fumihiko Makino, Asako Chiba, Hisaya Akiba, Ryo Atsuta, Sachiko Miyake, Kazuhisa Takahashi   +16 more
doaj   +1 more source